share_log

醫渡科技：授出股份獎勵

YIDU TECH: GRANT OF SHARE AWARDS

香港交易所 ·  Mar 27 07:34
Summary by Moomoo AI
醫渡科技於2024年3月27日宣布，根據首次公開發售後股份獎勵計劃，向12名獎勵承授人授出總計3,861,700股獎勵股份。該獎勵股份的授出旨在激勵員工及執行董事對公司的長期貢獻，並與公司業績目標掛鈎。其中，執行董事宮盈盈女士獲授1,000,000股獎勵股份。獎勵股份的歸屬期分別為2025年1月1日至2028年1月1日、2026年1月1日至2028年1月1日及2024年3月31日至2027年4月1日，並設有業績目標達成條件。本次授出後，公司尚有98,612,108股股份可供未來授出獎勵。該獎勵計劃有助於提升公司及其股份的價值，並無需經過股東批准。
醫渡科技於2024年3月27日宣布，根據首次公開發售後股份獎勵計劃，向12名獎勵承授人授出總計3,861,700股獎勵股份。該獎勵股份的授出旨在激勵員工及執行董事對公司的長期貢獻，並與公司業績目標掛鈎。其中，執行董事宮盈盈女士獲授1,000,000股獎勵股份。獎勵股份的歸屬期分別為2025年1月1日至2028年1月1日、2026年1月1日至2028年1月1日及2024年3月31日至2027年4月1日，並設有業績目標達成條件。本次授出後，公司尚有98,612,108股股份可供未來授出獎勵。該獎勵計劃有助於提升公司及其股份的價值，並無需經過股東批准。
Medical Technology announced on March 27, 2024 that it has granted a total of 3,861,700 share bonus shares to 12 award grantees under the Initial Public Offering Share Award Scheme. The award of the bonus shares is intended to motivate employees and executive directors to make long-term contributions to the company and is linked to the company's performance objectives. Of these, Ms. MIYing-ying, Executive Director, was granted 1,000,000 shares of bonus shares. The allotment periods for the bonus shares are from 1 January 2025 to 1 January 2028, 1 January 2026 to 1 January 2028 and 31 March 2024 to 1 April 2027, respectively, subject to the achievement of performance targets. Following this grant, the Company has 98,612,108 shares of common stock available for future awards. The reward scheme helps to increase the value of the company and its shares and does not require shareholder approval.
Medical Technology announced on March 27, 2024 that it has granted a total of 3,861,700 share bonus shares to 12 award grantees under the Initial Public Offering Share Award Scheme. The award of the bonus shares is intended to motivate employees and executive directors to make long-term contributions to the company and is linked to the company's performance objectives. Of these, Ms. MIYing-ying, Executive Director, was granted 1,000,000 shares of bonus shares. The allotment periods for the bonus shares are from 1 January 2025 to 1 January 2028, 1 January 2026 to 1 January 2028 and 31 March 2024 to 1 April 2027, respectively, subject to the achievement of performance targets. Following this grant, the Company has 98,612,108 shares of common stock available for future awards. The reward scheme helps to increase the value of the company and its shares and does not require shareholder approval.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more